- Home
- PRQR vs MIO Comparison
PRQR vs MIO Comparison
Compare PRQR & MIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- MIO
- Stock Information
- Founded
- PRQR 2012
- MIO 2021
- Country
- PRQR Netherlands
- MIO United States
- Employees
- PRQR N/A
- MIO N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- MIO Investment Managers
- Sector
- PRQR Health Care
- MIO Finance
- Exchange
- PRQR Nasdaq
- MIO Nasdaq
- Market Cap
- PRQR 179.1M
- MIO 200.3M
- IPO Year
- PRQR 2014
- MIO N/A
- Fundamental
- Price
- PRQR $2.30
- MIO $11.80
- Analyst Decision
- PRQR Strong Buy
- MIO
- Analyst Count
- PRQR 8
- MIO 0
- Target Price
- PRQR $8.88
- MIO N/A
- AVG Volume (30 Days)
- PRQR 362.3K
- MIO 46.0K
- Earning Date
- PRQR 08-07-2025
- MIO 01-01-0001
- Dividend Yield
- PRQR N/A
- MIO 4.57%
- EPS Growth
- PRQR N/A
- MIO N/A
- EPS
- PRQR N/A
- MIO N/A
- Revenue
- PRQR $21,212,711.00
- MIO N/A
- Revenue This Year
- PRQR N/A
- MIO N/A
- Revenue Next Year
- PRQR N/A
- MIO N/A
- P/E Ratio
- PRQR N/A
- MIO N/A
- Revenue Growth
- PRQR 85.91
- MIO N/A
- 52 Week Low
- PRQR $1.07
- MIO $9.18
- 52 Week High
- PRQR $4.62
- MIO $11.36
- Technical
- Relative Strength Index (RSI)
- PRQR 68.07
- MIO 49.33
- Support Level
- PRQR $2.10
- MIO $11.78
- Resistance Level
- PRQR $2.18
- MIO $11.85
- Average True Range (ATR)
- PRQR 0.13
- MIO 0.07
- MACD
- PRQR 0.01
- MIO -0.00
- Stochastic Oscillator
- PRQR 54.55
- MIO 47.06
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.